Skin / hair / cosmetic peptides
Peptides studied mostly in topical/cosmetic contexts for skin and collagen biology.
S is approval-grade evidence; F is documented harm or near-zero human data. Each bar is how many peptides on this page land in that tier — a fast read on how much of this category sits in approval-grade evidence versus thin or vendor-driven claims.
The category at a glance
Every compound here ranked S–F by its weighted evidence score — strongest human / approval-grade evidence at the top, thin or vendor-driven claims at the bottom. Tap any row for the evidence read. Popularity never raises a tier.
Receipts, not vendor theater. Every tier here is computed from published evidence and regulatory status — not vendor marketing or influencer claims. See how we score.
Dghk-cuEarly human evidenceMedium overstatementResearch-use-only45/ 100
A copper-binding tripeptide with the most evidence in topical/cosmetic skin contexts (collagen, antioxidant and regenerative signalling). Systemic/injectable human evidence is limited; much of the support is in-vitro or small skin studies. Reasonable cosmetic rationale, thin systemic data.
Tier read: early human evidence · medium overstatement risk · low search interest · Early human. Why not F: supported by preclinical depth. Why not C: held back by human evidence, regulatory clarity.
Read the full ghk-cu profile →DargirelineEarly human evidenceMedium overstatementResearch-use-only39/ 100
A topical cosmetic peptide (acetyl hexapeptide-3/8) modelled on SNAP-25, claimed to soften expression lines by interfering with neurotransmitter release. Evidence is small, short-term cosmetic studies (e.g. reduced periorbital wrinkle roughness vs placebo over 4 weeks); effects are modest and below pharmaceutical standards.
Tier read: early human evidence · medium overstatement risk · low search interest · Early human. Why not F: supported by its overall evidence profile. Why not C: held back by human evidence, preclinical depth, regulatory clarity.
Read the full argireline profile →DmatrixylEarly human evidenceMedium overstatementResearch-use-only37/ 100
A topical cosmetic signal peptide (palmitoyl pentapeptide / pal-KTTKS) intended to stimulate dermal matrix synthesis. Supporting data are small split-face cosmetic trials showing modest fine-line improvement with good tolerability — cosmetic and incremental, not clinically dramatic.
Tier read: early human evidence · medium overstatement risk · low search interest · Early human. Why not F: supported by its overall evidence profile. Why not C: held back by human evidence, preclinical depth, mechanism confidence, regulatory clarity.
Read the full matrixyl profile →Fptd-dbmWeak human evidenceHigh overstatementResearch-use-only12/ 100
A cell-penetrating peptide that activates Wnt/β-catenin signalling (disrupting CXXC5–Dishevelled), with reported hair-regrowth effects in mouse models. Evidence is animal/lab only — no completed human efficacy trials. Investigational, not an approved hair-loss treatment.
Tier read: weak human evidence · high overstatement risk · low search interest · Anecdote. Why not D: held back by human evidence, preclinical depth, mechanism confidence, safety clarity, regulatory clarity, practical relevance.
Read the full ptd-dbm profile →Skin, hair, and cosmetic peptides are mostly a topical story. The better-supported compounds here work in creams and serums on skin biology; the weakest claims are the systemic “anti-aging from a peptide” ones that the cosmetic evidence never established.
What the evidence actually supports
Topical cosmetic peptides — GHK-Cu (a copper tripeptide), Matrixyl (a palmitoyl peptide), and Argireline (acetyl hexapeptide) — are studied for collagen/matrix support and softening expression lines, in cosmetic contexts. The effects are real but modest and local.
Where the hype outruns the data
“Reverses aging,” “guaranteed regrowth,” and systemic anti-aging from a topical are not what the evidence shows. Argireline is far weaker than the injectable it's compared to; hair-regrowth peptides like PTD-DBM are mostly animal-stage.
FAQ
Do skin peptides actually work?
Topically, the cosmetic evidence for collagen/skin support is reasonable but modest. Systemic anti-aging claims are not established.
Will peptides regrow hair?
Hair-regrowth peptide evidence is early and mostly preclinical; it isn't well established in controlled human studies.
Is this medical advice?
No — research reference only.
Research reference only. Not medical advice, dosing, or a recommendation to use any compound. “Worth watching” ≠ proven or safe.